Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diuretic crossover trial for antiproteinuric effect in chronic proteinuric nephropathies
2011-001929-24Phase 4Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital 12 de Octubre
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic kidney disease (CKD) comparing Hydrochlorothiazide sequence, Amiloride + hydrochlorothiazide sequence and Spironolactone sequence (3 arms). Primary endpoint: Percentage reduction in albuminuria/proteinuria. Started Aug 2011; status: active.
02
Drugs
hydrochlorothiazideamiloridespironolactone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2011-001929-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001929-24.